<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> and loss of <z:chebi fb="105" ids="17234">glucose</z:chebi>-stimulated <z:hpo ids='HP_0011009'>acute</z:hpo> insulin response (AIR) are the two major and earliest defects in the course of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated whether <z:hpo ids='HP_0001824'>weight loss</z:hpo> after bariatric surgery in patients with morbid <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> could restore euglycemia and <z:mpath ids='MPATH_458'>normal</z:mpath> AIR to an intravenous <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (IVGTT) </plain></SENT>
<SENT sid="2" pm="."><plain>We studied 25 morbidly <z:mp ids='MP_0001261'>obese</z:mp> patients-12 with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, 5 with <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo>, and 8 with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT)-before and after a biliopancreatic diversion (BPD) with Roux-en-Y gastric bypass (RYGBP) </plain></SENT>
<SENT sid="3" pm="."><plain>Twelve individuals with <z:mpath ids='MPATH_458'>normal</z:mpath> BMI served as control subjects </plain></SENT>
<SENT sid="4" pm="."><plain>Twelve months after surgery, in the <z:mp ids='MP_0002055'>diabetes</z:mp> group, BMI decreased from 53.2 +/- 2.0 to 29.2 +/- 1.7 kg/m(2), fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> decreased from 9.5 +/- 0.83 to 4.5 +/- 0.13 mmol/l, and fasting insulin decreased from 168.4 +/- 25.9 to 37.7 +/- 4.4 pmol/l (mean +/- SE; P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>AIR, the mean of insulin concentration at 2, 3, and 5 min over basal in the IVGTT, increased by 770 and 935% at 3 and 12 months after surgery, respectively (from 24.0 +/- 22.7 to 209 +/- 43.4 and 248 +/- 33.1 pmol/l, respectively; P &lt; 0,001) </plain></SENT>
<SENT sid="6" pm="."><plain>Conversely, in the NGT group, the AIR decreased by 40.5% (from 660 +/- 60 to 393 +/- 93 pmol/l; P = 0.027) 12 months after surgery </plain></SENT>
<SENT sid="7" pm="."><plain>BPD with RYGBP performed in morbidly <z:mp ids='MP_0001261'>obese</z:mp> patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> leads to significant <z:hpo ids='HP_0001824'>weight loss</z:hpo>, euglycemia, and <z:mpath ids='MPATH_458'>normal</z:mpath> insulin sensitivity; but most importantly, it restores a <z:mpath ids='MPATH_458'>normal</z:mpath> beta-cell AIR to <z:chebi fb="105" ids="17234">glucose</z:chebi> and a <z:mpath ids='MPATH_458'>normal</z:mpath> relationship of AIR to insulin sensitivity </plain></SENT>
<SENT sid="8" pm="."><plain>This is the first study to demonstrate that the lost <z:chebi fb="105" ids="17234">glucose</z:chebi>-induced AIR in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> of mild or moderate severity is a reversible abnormality </plain></SENT>
</text></document>